China SXT Pharmaceuticals, Inc. Class A Ordinary Shares (SXTC)

Price$1.68

Value ScoreA

Growth ScoreF

Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-115.10%

Price vs S&P 500 (4W)-24.30%

VGM Score41.69

Market Capitalization$1.60M

All Metrics

Book Value / Share (Quarterly)$26.14

P/TBV (Annual)2.23x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-12.51%

Cash Flow / Share (Quarterly)$-3.54

Price vs S&P 500 (YTD)-110.24%

Gross Margin (TTM)21.74%

Net Profit Margin (TTM)-576.72%

EPS (TTM)$-161.77

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-161.77

Revenue Growth (5Y)-19.53%

EPS (Annual)$-348.12

ROI (Annual)-20.33%

Gross Margin (Annual)21.11%

Net Profit Margin (5Y Avg)-185.95%

Cash / Share (Quarterly)$27.35

Revenue Growth QoQ (YoY)-24.46%

ROA (Last FY)-15.25%

Revenue Growth TTM (YoY)-15.42%

EBITD / Share (TTM)$-21.12

ROE (5Y Avg)-27.24%

Operating Margin (TTM)-544.94%

Cash Flow / Share (Annual)$-25.57

P/B Ratio0.08x

P/B Ratio (Quarterly)9.00x

Net Income / Employee (Annual)$-44,000

EV / Revenue (TTM)-12.04x

Net Interest Coverage (TTM)-4.10x

ROA (TTM)-36.94%

EV / EBITDA (TTM)-2.91x

EPS Incl Extra (Annual)$-348.12

Current Ratio (Annual)3.54x

Quick Ratio (Quarterly)4.06x

3-Month Avg Trading Volume0.19M

52-Week Price Return-99.24%

Revenue / Employee (TTM)$20,500

Tangible BV / Share (Quarterly)$26.13

P/S Ratio (Annual)0.92x

Asset Turnover (Annual)0.08x

52-Week High$1046.98

Operating Margin (5Y Avg)-162.96%

EPS Excl Extra (Annual)$-348.12

CapEx CAGR (5Y)-65.44%

Tangible BV CAGR (5Y)10.53%

26-Week Price Return-99.17%

Quick Ratio (Annual)3.35x

13-Week Price Return-30.99%

Total Debt / Equity (Annual)0.05x

Current Ratio (Quarterly)4.37x

Enterprise Value$-18.51M

Revenue / Share Growth (5Y)-18.68%

Asset Turnover (TTM)0.06x

Book Value / Share Growth (5Y)-18.58%

Revenue / Employee (Annual)$23,200

Inventory Turnover (Annual)1.69x

Pretax Margin (Annual)-189.77%

Cash / Share (Annual)$197.16

3-Month Return Std Dev99.94%

Gross Margin (5Y Avg)35.83%

Net Income / Employee (TTM)$-118,300

ROE (Last FY)-21.40%

Net Interest Coverage (Annual)-16.84x

EPS Basic Excl Extra (Annual)$-348.12

P/FCF (TTM)3.81x

Receivables Turnover (TTM)1.51x

Total Debt / Equity (Quarterly)0.05x

EPS Incl Extra (TTM)$-161.77

Receivables Turnover (Annual)2.07x

ROI (TTM)-47.26%

P/S Ratio (TTM)1.04x

Pretax Margin (5Y Avg)-184.21%

Revenue / Share (Annual)$183.45

Tangible BV / Share (Annual)$168.06

Price vs S&P 500 (52W)-127.44%

Year-to-Date Return-99.30%

5-Day Price Return0.60%

EPS Normalized (Annual)$-348.12

ROA (5Y Avg)-14.76%

Net Profit Margin (Annual)-189.77%

Month-to-Date Return-18.93%

Cash Flow / Share (TTM)$-21.29

EBITD / Share (Annual)$-274.54

Operating Margin (Annual)-153.97%

LT Debt / Equity (Annual)0.01x

ROI (5Y Avg)-24.05%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-161.77

P/TBV (Quarterly)9.01x

P/B Ratio (Annual)2.22x

Inventory Turnover (TTM)1.49x

Pretax Margin (TTM)-576.72%

Book Value / Share (Annual)$168.19

Price vs S&P 500 (13W)-40.74%

Beta1.83x

P/FCF (Annual)7.62x

Revenue / Share (TTM)$1.99

ROE (TTM)-49.73%

52-Week Low$1.25

vGradeA

gGradeF

mGradeF

vgmGradeC

Show chart for

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
SXTCChina SXT Pharmaceuticals, Inc. Class A Ordinary Shares	A	F	F	$1.68
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
ABTAbbott Laboratories	C	C	D	$87.78
PFEPfizer Inc.	B	C	C	$25.63
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

China SXT Pharmaceuticals manufactures and markets Traditional Chinese Medicine Pieces (TCMP), specializing in pre-processed, ready-to-use formulations that eliminate decoction. All revenue is generated from the People's Republic of China.